LOCATIONTITLE
Journal of Ocular Pharmacology and TherapeuticsMuya, et al - Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the ChorioretinaVIEWUveitic Macular Edema
Angiogenesis 2022Ciulla, Thomas A – The Suprachoroidal Space and Suprachoroidal Delivery for CliniciansVIEWSuprachorodial Space and Microinjector
AAO 2021Grewal et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular EdemaVIEWUveitic Macular Edema
AAO 2021Henry et al - Post-Hoc Analysis of Suprachoroidal CLS-TA vs. Rescue Therapies in Macular Edema associated with Noninfectious UveitisVIEWUveitic Macular Edema
AAO 2021Reddy et al - Uveitic Macular Edema: Visual Function and Ocular Anatomy by Severity of Vision LossVIEWUveitic Macular Edema
AUS Fall 2021Yeh et al - Suprachoroidal SCS-TA Safety and Efficacy in Macular Edema Associated with Uveitis: Post Hoc Analysis of Clinically Relevant SubgroupsVIEWUveitic Macular Edema
AUS Fall 2021Kurup et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal ImagingVIEWSuprachorodial Space and Microinjector
ASRS 2021Major et al - Suprachoroidal Administration of Small Molecule Suspensions: Pre-Clinical Results Correlate to Clinical Trial OutcomesVIEWSuprachorodial Space and Microinjector
ASRS 2021Hu et al - Safety of the Suprachoroidal Injection Procedure Via Microinjector across Three Retinal DisordersVIEWSuprachorodial Space and Microinjector
ASRS 2021Kurup et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal ImagingVIEWSuprachorodial Space and Microinjector
ASRS 2021Grewal et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular EdemaVIEWUveitic Macular Edema
ASRS 2021Yeh et al - Post Hoc Analysis of Suprachoroidal CLS-TA versus Real World Rescue Therapies for Uveitic Macular Edema: Safety and Visual FunctionVIEWUveitic Macular Edema
Retina Society 2021Albini et al - OCT Anatomic & Temporal Biomarkers in Uveitic Macular EdemaVIEWUveitic Macular Edema
Retina Society 2021Marcus et al - Comparison of Suprachoroidal and Intravitreal Injection Flow Mechanics Analyzed via Multimodal ImagingVIEWSuprachorodial Space and Microinjector
Retina Society 2021MacCumber et al - Safety of the Suprachoroidal Injection Procedure Utilizing SCS Microinjector® across Three Retinal Disorders​VIEWSuprachorodial Space and Microinjector
Retina Society 2021Dayani et al - Safety and Visual Function of Suprachoroidal CLS-TA versus Real World Rescue Therapies for Macular Edema associated with Noninfectious Uveitis: A Post-hoc AnalysisVIEWUveitic Macular Edema
Retina Society 2021Henry et al - Visual Function and Anatomic Outcomes Stratified by Baseline Visual Acuity in Patients Undergoing Suprachoroidal Injections for Macular Edema Associated with Noninfectious UveitisVIEWUveitic Macular Edema
Ocular Immunology & InflammationMerrill et al - Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical TrialVIEWUveitic Macular Edema
Translational Vision Science & TechnologyKansara et al - Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in RabbitsVIEWCLS-AX (axitinib injectable suspension)
ARVO 2021Sharma et al - Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector Across Three Retinal DisordersVIEWSuprachorodial Space and Microinjector
ARVO 2021Shah et al - Post-Hoc Analysis of Suprachoroidal Injection Experience for Non-Infectious UveitisVIEWUveitic Macular Edema
ARVO 2021Muya et al - Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edemaVIEWDiabetic Macular Edema
ARVO 2021Kansara et al - Suprachoroidally delivered non-viral DNA nanoparticles produce hMyo7A Protein in RPE-choroid in rabbitsVIEWGene Therapy
ARVO 2021Ho et al - Suprachoroidal Injections Across Species via Multimodal ImagingVIEWSuprachorodial Space and Microinjector
ARVO 2021Goldstein et al - Uveitic Macular Edema: OCT Anatomic and Temporal BiomarkersVIEWUveitic Macular Edema
ARVO 2021Fisher et al - Ophthalmic Procedure Training During COVID-19: Virtual and In-Person Training of the Suprachoroidal Injection ProcedureVIEWSuprachorodial Space and Microinjector
British Journal of OphthalmologyKuhrana et al - Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)VIEWUveitic Macular Edema
British Journal of OphthalmologyHenry et al - Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)VIEWUveitic Macular Edema
Multidisciplinary Digital Publishing InstituteCiulla et al - Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular DiseasesVIEWSuprachorodial Space and Microinjector
Angiogenesis 2021Video - Brown - Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMD, Clinical trial injection procedure after (dark orange) Betadine Ophthalmic PrepVIEWCLS-AX (axitinib injectable suspension)
Angiogenesis 2021Presentation - Brown - Axitinib: A Novel TKI Delivered by Suprachoroidal Injection for AMDVIEWCLS-AX (axitinib injectable suspension)
Macula Society 2021Suhler et al - Post Hoc Analysis of Suprachoroidal CLS-TA versus Rescue Therapies for Uveitic Macular Edema: Safety and Visual FunctionVIEWUveitic Macular Edema
Macula Society 2021Grewal et al - OCT Anatomic and Temporal Biomarkers in Uveitic Macular EdemaVIEWUveitic Macular Edema
Macula Society 2021MacCumber et al - Suprachoroidal Administration of Small Molecule and Nanoparticle Suspensions: Pre-Clinical Results Correlate to Clinical Trial OutcomesVIEWCLS-AX (axitinib injectable suspension)
Macula Society 2021Kurup et al - Safety of the Suprachoroidal Injection Procedure Utilizing SCS Microinjector® across Three Retinal DisordersVIEWSuprachorodial Space and Microinjector
Macula Society 2021Hariprasad et al - Multimodal Imaging of Suprachoroidal Injections: A Retina Surgeon’s PerspectiveVIEWSuprachorodial Space and Microinjector
Expert Opinion on Drug DeliveryHancock et al - Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapiesVIEWSuprachorodial Space and Microinjector
Translational Vision Science & TechnologyKansara, et al - Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in RabbitsVIEWGene Therapy
AAO 2020Nguyen - Results from the Phase 3 PEACHTREE Clinical Trial Systemic Therapy and the Efficacy of CLS-TA: a Post-Hoc AnalysisVIEWUveitic Macular Edema
AAO 2020Bhisitkul et al - Suprachoroidal CLS-AX (axitinib injectable suspension) as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)VIEWCLS-AX (axitinib injectable suspension)
Translational Vision Science & TechnologyWan et al – Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal DisordersVIEWSuprachorodial Space and Microinjector
Ophthalmology RetinaSuprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled StudyVIEWDiabetic Macular Edema
Retina Society 2020Ip - Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and UveitisVIEWRetinal Vein Occlusion
Retina Society 2020Ciulla - Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: An Analysis of 12,214 EyesVIEWRetinal Vein Occlusion
Retina Society 2020Merrill - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc AnalysisVIEWUveitic Macular Edema
Retina Society 2020Holekamp - Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbitsVIEWGene Therapy
Retina Society 2020Kim - Suprachoroidal Delivery of Small Molecule Suspensions and NanoparticlesVIEWSuprachorodial Space and Microinjector
Retina Society 2020Henry - Post hoc Analysis of Clinical Suprachoroidal Injection Experience Across IndicationsVIEWSuprachorodial Space and Microinjector
Retina Society 2020Brown - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)VIEWCLS-AX (axitinib injectable suspension)
ARVO 2020Fisher - Suprachoroidal Delivery with the SCS Microinjector®: Characterization of Operational ForcesVIEWSuprachorodial Space and Microinjector
ARVO 2020Barakat et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across IndicationsVIEWSuprachorodial Space and Microinjector
ARVO 2020Muya et al - Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension)VIEWCLS-AX (axitinib injectable suspension)
ARVO 2020Kaiser et al - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)VIEWCLS-AX (axitinib injectable suspension)
ARVO 2020Grewal et al - Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and UveitisVIEWRetinal Vein Occlusion
ARVO 2020Henry et al - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc AnalysisVIEWUveitic Macular Edema
ASRS 2020Henry et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience Across Retinal Disease IndicationsVIEWSuprachorodial Space and Microinjector
ASRS 2020Kurup et al - Post Hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious UveitisVIEWSuprachorodial Space and Microinjector
ASRS 2020Nguyen - Variations in Intraocular Pressure Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) Results from the Phase 3 PEACHTREE Clinical Trial for Uveitic Macular EdemaVIEWUveitic Macular Edema
ASRS 2020Reddy et al - Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc AnalysisVIEWUveitic Macular Edema
Journal of Ocular Pharmacology and Therapeutics 2020Viral Kinsara - Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal DiseasesVIEWGene Therapy
Ophthalmology 2020Yeh et al - Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3, Randomized TrialVIEWUveitic Macular Edema
Macula Society 2020Kurup - Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)VIEWCLS-AX (axitinib injectable suspension)
Macula Society 2020Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Analysis of OCT Biomarkers in the Randomized Phase 2 TYBEE TrialVIEWDiabetic Macular Edema
Macula Society 2020Singer - IOP Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA): Results from the Phase 3 PEACHTREE Clinical Trial for UveitisVIEWUveitic Macular Edema
Macula Society 2020MacCumber - Suprachoroidal Delivery for Ocular Gene Therapy: Nonclinical Experiments Evaluating Non-Viral DNA Nanoparticles in Non-Human PrimatesVIEWGene Therapy
Angiogenesis 2020Albini - Update on Therapeutic Suprachoroidal InjectionsVIEWSuprachorodial Space and Microinjector
Angiogenesis 2020Yeh - Front-line Local Therapies for Uveitis: From Clinical Trials to PracticeVIEWUveitic Macular Edema
RETINA 2019Stephen Yeh - Suprachoroidal Injection of Triamcinolone Acetonide, CLS-TA, for Macular Edema Due to Noninjectious Uveitis: A Randomized, Phase 2 Study (DOGWOOD)VIEWUveitic Macular Edema
Experimental Eye Research 2019Jae Hwan Jung - Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targetingVIEWSuprachorodial Space and Microinjector
Drug Discovery Today 2019Jae Hwan Jung - Targeting drug delivery within the suprachoroidal spaceVIEWSuprachorodial Space and Microinjector
Acta Ophthalmologica 2019Habot-Wilner - Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approachVIEWSuprachorodial Space and Microinjector
AAO 2019Levison - A Subgroup Analysis of Subjects Diagnosed with Anterior Uveitis from the Phase 3 PEACHTREE Clinical TrialVIEWUveitic Macular Edema
AAO 2019Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Selected Secondary Results of the Randomized Phase 2 TYBEE TrialVIEWDiabetic Macular Edema
AAO 2019Yeh - Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) and Intraocular Pressure: Results from the Phase 3 PEACHTREE Clinical Trial for UveitisVIEWUveitic Macular Edema
AAO 2019Kay - Suprachoroidal delivery for ocular gene therapy: nonclinical experiments evaluating non-viral DNA nanoparticles.VIEWGene Therapy
Retina Society 2019Merrill – Suprachoroidal Triamcinolone Acetonide Suspension (CLS-TA) and Intraocular Pressure: Results from the Phase 3 PEACHTREE Clinical Trial for UveitisVIEWUveitic Macular Edema
Retina Society 2019Sharma - Suprachoroidal CLS-TA Maintains Efficacy Outcomes Through 48-weeks in Uveitic Macular Edema subjects: Results of the MAGNOLIA Phase 3 Extension StudyVIEWUveitic Macular Edema
EURETINA 2019Neumann – Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE StudyVIEWUveitic Macular Edema
ASRS 2019Ip - Suprachoroidal CLS-TA Plus Aflibercept Compared with Aflibercept Monotherapy for DME: Primary and Selected Secondary Results of the Randomized Phase 2 TYBEE TrialVIEWDiabetic Macular Edema
ASRS 2019Henry - Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE StudyVIEWUveitic Macular Edema
ASRS 2019Merrill - Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks: Results of the MAGNOLIA Phase 3 Extension StudyVIEWUveitic Macular Edema
ARVO 2019Henry - Treatment response analysis of visual acuity and central subfield retinal thickness following suprachoroidal CLS-TAVIEWUveitic Macular Edema
ARVO 2019Suhler - Suprachoroidal Administration of Triamcinolone Acetonide (CLS-TA) for the treatment of Macular Edema in Noninfectious Uveitis: Pooled Results of Three Clinical TrialsVIEWUveitic Macular Edema
Macula Society 2019Yeh - Suprachoroidal CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveitis: Results of the Phase 3 PEACHTREE StudyVIEWUveitic Macular Edema
ASRS 2019Kay - Suprachoroidal administration of DNA nanoparticles transfect chorioretinal cells in primates and rabbits. Click here for video presentationVIEWGene Therapy
Macula Society 2019Hariprasad - Suprachoroidally Injected CLS-TA Results in Rapid and Sustained Resolution of Macular Edema in a Majority of PatientsVIEWUveitic Macular Edema
AUS Winter 2019Henry - Suprachoroidal Delivery of CLS-TA for Uveitic Macular Edema: Results of the Phase 3 PEACHTREE TrialVIEWUveitic Macular Edema
ARVO 2019Kansara - Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbitsVIEWGene Therapy
Macula Society 2019Kiss - A Novel Approach to Ocular Gene Therapy: Evaluation of Suprachoroidally Administered Non-Viral DNA Nanoparticles in RabbitsVIEWGene Therapy
AUS Winter 2019Merrill - Suprachoroidal CLS-TA Maintains Efficacy Outcomes Through 48-weeks in Uveitic Macular Edema subjects: Results of the MAGNOLIA Phase 3 Extension StudyVIEWUveitic Macular Edema
ASRS 2019Shah - Clinical Experience with the SCS Microinjector™ for Suprachoroidal Injections by OphthalmologistsVIEWSuprachorodial Space and Microinjector
Macula Society 2019Wykoff - Suprachoroidal CLS-TA Plus Aflibercept Compared to Aflibercept Monotherapy for DME: Results of the Randomized Phase 2 TYBEE TrialVIEWDiabetic Macular Edema
Ophthalmology Retina 2018Charles C. Wykoff - Suprachoroidal Triamcinolone for Diabetic Macular Edema: The HULK TrialVIEWDiabetic Macular Edema
ASRS 2018Yeh, S. - Suprachoroidally Injected CLS-TA Improves Visual Acuity and Macular Edema in Noninfectious Uveities Results of the Phase 3 PEACHTREE StudyVIEWUveitic Macular Edema
Advanced Drug Delivery Reviews 2018Bryce Chiang - The suprachoroidal space as a route of administration to the posterior segment of the eyeVIEWSuprachorodial Space and Microinjector
American Journal of Ophthalmology 2018Alex S. Willoughby - Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein OcclusionVIEWRetinal Vein Occlusion
Opthalmology Retina 2018Peter A. Campochiaro - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite StudyVIEWRetinal Vein Occlusion
OSLI Retina 2018Shaun I. R. Lampen - Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular EdemaVIEWDiabetic Macular Edema
ARVO 2018Taraborelli, D., Noronha, G., Yoo, J., Laird, O., Cooper, M. - A One-week Study to Evaluate Safety, Tolerability, and Retinal Cell Transfection of Non-viral DNA Nanoparticles Administered by Suprachoroidal InjectionVIEWGene Therapy
ARVO 2010Patel SR, Berezovsky D, McCarey BE, Nickerson JM, Edelhauser HF, Prausnitz MR. - Intraocular Pharmacokinetics of Suprachoroidal Drug Delivery Administered Using Hollow Microneedles.VIEWSuprachorodial Space and Microinjector
ARVO 2014Patel SR, Verhoeven RS, Burke B, Viaud K, Edelhauser HF. Safety and Tolerability of Drugs Within the Suprachoroidal Space in Albino Rabbits. ARVO Meeting Abstracts 2014; 4886-C0082.VIEWSuprachorodial Space and Microinjector
ARVO 2016Kissner J, Patel S, Prusakiewicz J, Alton D, Bikzhanova G, Geisler L, Burke B, Noronha G. Pharmacokinetics Including Ocular Distribution Characteristics of Suprachoidally Administered CLS011A in Rabbits Could be Beneficial for a Wet AMD Therapeutic CandidateVIEWWet AMD
ARVO 2017Burke, B. - Targeted delivery of Triamcinolone Acetonide and CLS011A To the posterior ocular tissues via Suprachoroidal administrationVIEWUveitic Macular Edema
ARVO 2017Shah, M. - Development and clinical experience with Suprachoroidal injection of Triamcinolone acetonide (CLS-TA) as a local treatment for noninfectious uveitisVIEWUveitic Macular Edema
AAO 2017 (RVO)Campochiaro, P., Wykoff, C., Brown, C. - Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite StudyVIEWRetinal Vein Occlusion
Retina Society 2017Hariprasad, S. - Patient Safety Data Across Clinical Trials Using Suprachoroidal Injection of Triamcinolone AcetonideVIEWUveitic Macular Edema
2017 (RVO)Michael Singer, MD - Tanzanite Phase 2 Retinal vein occlusion (RVO) trialVIEWRetinal Vein Occlusion
AUS 2017Wang, R. - The potential for treatment of noninfectious uveitis using a suprachoroidal approachVIEWUveitic Macular Edema
2017 (RVO)Wykoff C. Durability of Suprachoroidal Triamcinolone Acetonide in Combination with Aflibercept in the Management of Retinal Vein Occlusion: 9-Month Analysis of the TANZANITE Phase 2 Trial and Extension StudyVIEWRetinal Vein Occlusion
2017Wykoff, C., Khurana, R. - Suprachoroidal Triamcinolone Acetonide with & without Intravitreal Aflibercept for DME: Results of the 6 Month Prospective Phase 1/2 Hulk trialVIEWDiabetic Macular Edema
2017Yoo, J - Characterization of the dynamics of liquid and gel spread in the Suprachoroidal space of enucleated porcine eyesVIEWSuprachorodial Space and Microinjector
TVST 2016Goldstein D, Do D, Noronha G, Kissner J, Srivastava S, Nguyen Q. - Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious UveitisVIEWUveitic Macular Edema
ASRS 2016Yeh S. - Suprachoroidal Administration of Triamcinolone Acetonide: Results of a Phase 2 Study of Patients with Noninfectious UveitisVIEWUveitic Macular Edema
2016Do D. - Clinical Trial Results From Patients With Macular Edema Due to Noninfectious Uveitis Treated With 4.0 mg of Triamcinolone Acetonide Using a Suprachoroidal InjectionVIEWUveitic Macular Edema
Translational Vision Science and Technology 2016Debra A. Goldstein - Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious UveitisVIEWUveitic Macular Edema
Clinical Ophthalmology 2016Ela Moisseiev - The suprachoroidal space: from potential space to a space with potentialVIEWSuprachorodial Space and Microinjector
Journal of Ocular Pharmacology and Therapeutics 2016Samirkumar R. Patel - Targeted Drug Delivery Within the Eye Through the Suprachoroidal SpaceVIEWSuprachorodial Space and Microinjector
ARVO 2016Brown D. Suprachoroidal Triamcinolone Acetonidewith Intravitreal Aflibercept For Retinal Vein Occlusion: Phase 2 Results –TANZANITE studyVIEWRetinal Vein Occlusion
ARVO 2018Fisher, N., Yoo, J., Hancock, S., Andino, R. - A Novel Technique to Characterize Key Fluid Mechanic Properties of the Suprachoroidal Injection Procedure in an In Vivo ModelVIEWSuprachorodial Space and Microinjector
ASRS 2016Hariprasad S. - Suprachoroidal Administration of Triamcinolone Acetonide: Combined Results of Phase 1/2 and Phase 2 Clinical StudiesVIEWUveitic Macular Edema
ASRS 2016Kurup S. - Suprachoroidal Drug AdministrationVIEWSuprachorodial Space and Microinjector
ARVO 2016Patel S, Kissner J, Zarnitsyn V, Farjo R, Noronha G. - Efficacy of Suprachoroidal Aflibercept in a Laser Induced Choroidal Neovascularization Model.VIEWSuprachorodial Space and Microinjector
ARVO 2016Taraborelli D, Burke B, Noronha G. Ocular Tolerability and Toxicokinetics of Suprachoroidally Administered CLS-TA, Triamcinolone Acetonide Injectable Suspension, in Combination with Intravitreal Eylea® in Rabbits. ARVO Meeting Abstracts 2016; 296-B0329.VIEWDiabetic Macular Edema
ARVO 2016Zarnitsyn V, Patel S, Yoo J, Noronha G. - Characterization of Suprachoroidal Injection in Multiple Species.VIEWSuprachorodial Space and Microinjector
ARVO 2016 (wet-AMD)Wet AMD Kissner J, Patel S, Prusakiewicz J, Alton D, Bikzhanova G, Geisler L, Burke B, Noronha G. – Pharmacokinetics Including Ocular Distribution Characteristics of Suprachoroidally Administered CLS011A in Rabbits Could be Beneficial for a Wet AMD...VIEWWet AMD
ARVO 2013 (wet-AMD)Wet AMD Morales-Canton V, Fromow-Guerra J, Longoria S, Vera R, Widmann M, Patel S, Yerxa B. – Suprachoroidal Microinjection of Bevacizumab is Well Tolerated in Human PatientsVIEWWet AMD
Drug Discovery Today 2015Uma Do J.P. Rai - The suprachoroidal pathway: a new drug delivery route to the back of the eyeVIEWSuprachorodial Space and Microinjector
ARVO 2014Andino RV, Allen EV, Patel SR, Edelhauser HF, Yoo JI. - Intraocular Pressure Changes Resulting from Suprachoroidal and Intravitreal Injections in Ex-Vivo Porcine Eyes.VIEWSuprachorodial Space and Microinjector
ARVO 2014Edelhauser HF, Verhoeven RS, Burke B, Struble CB, Patel SR. - Intraocular Distribution and Targeting of Triamcinolone Acetonide Suspension Administered into the Suprachoroidal Space.VIEWSuprachorodial Space and Microinjector
ARVO 2014Noronha G, Edelhauser HF, Patel SR, Burke B, Verhoeven RS. Safety and Toxicokinetics of Suprachoroidal Space Injections of Triamcinolone Acetonide Suspension in Albino Rabbits. ARVO Meeting Abstracts 2014; 4887-C0083.VIEWSuprachorodial Space and Microinjector
ARVO 2014Yoo JI, A32c03ndino RV, Zarnitsyn V, Strudthoff K, Patel SR, Edelhauser HF. - Ultrasound Biomicrocopy to Visualize Suprachoroidal Injections of Enucleated Human Eyes.VIEWSuprachorodial Space and Microinjector
ARVO 2014Zarnitsyn V, Patel SR, Verhoeven RS, Lawrence MS. - Characterization of Sodium Fluorescein Administered into the Suprachoroidal Space of Nonhuman Primates Using a Microneedle.VIEWSuprachorodial Space and Microinjector
ARVO 2013Morales-Canton V, Fromow-Guerra J, Longoria S, Vera R, Widmann M, Patel S, Yerxa B. Suprachoroidal Microinjection of Bevacizumab is Well Torerated in Human Patients. ARVO Meeting Abstracts 2013;3299-A0150.VIEWSuprachorodial Space and Microinjector
ARVO 2013Burke B, Verhoeven R, Patel S. - Comparison of the Total Amount of Triamcinolone Acetonide Delivered Via Suprachoroidal or Intravitreal Administration.VIEWSuprachorodial Space and Microinjector
ARVO 2013Edelhauser H, Patel S, Meschter C, Dean R, Powell K, Verhoeven R. - Suprachoroidal Microinjection Delivers Triamcinolone Acetonide to Therapeutically-Relevant Posterior Ocular Structures and Limits Exposure in the Anterior Segment. ARVO Meeting AbstractsVIEWSuprachorodial Space and Microinjector
ARVO 2013Gilger B, Abarca E, Salmon J, Patel S. - Treatment of Acute Posterior Uveitis by Injection of Triamcinolone Acetonide into the Suprachoroidal Space Using Microneedles.VIEWUveitic Macular Edema
ARVO 2013Patel S, Carvalho R, Mundwiler K, Meschter C, Verhoeven R. - Evaluation of Suprachoroidal Microinjection of Triamcinolone Acetonide in a Model of Panuveitis in Albino Rabbits.VIEWSuprachorodial Space and Microinjector
ARVO 2013Verhoeven R, Patel S, Viaud-Quentric K, Cacciamani F, Amar T, Yerxa B. - Suprachoroidal Microinjection of Triamcinolone Acetonide is Well Tolerated in the Albino Rabbit.VIEWSuprachorodial Space and Microinjector
Investigative Ophthalmology and Visual Science 2012Smirkumar R. Patel - Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the EyeVIEWSuprachorodial Space and Microinjector
ARVO 2012Berezovsky DE, Patel SR, Grossniklaus HE, Edelhauser HF. - Microneedle-Based Suprachoroidal Injections in Rabbits: Histological Study Using Triamcinolone Acetonide. ARVO Meeting Abstracts 2012;53:486.VIEWSuprachorodial Space and Microinjector
ARVO 2012Mansoor S, Patel SR, Tas C, et al. - Pharmacokinetics and Biodistribution of Bevacizumab Following Suprachoroidal Injection into the Rabbit Eye Using a Microneedle.VIEWSuprachorodial Space and Microinjector
ARVO 2012Patel SR, Powers E, Prausnitz MR, Edelhauser HF. - Fluid Infusion Into the Corneal Stroma Using a Microneedle.VIEWSuprachorodial Space and Microinjector
6TCBio 2012Patel SR. - Microneedle Enabled Tissue Targeted Drug Delivery for the Anterior and Posterior Segment of the Eye.VIEWSuprachorodial Space and Microinjector
Multidisciplinary Ophthalmic Imaging 2011Gabriela S. Seiler - Effect and Distribution of Contrast Medium after Injection into the Anterior Suprachoroidal Space in Ex Vivo EyesVIEWSuprachorodial Space and Microinjector
ARVO 2011Berezovsky DE, Patel SR, McCarey BE, Grossniklaus HE, Prausnitz MR, Edelhauser HF. In Vivo Evaluation of Fluorescent Microparticles Injected in the Rabbit Suprachoroidal Space Using Hollow Microneedles. ARVO Meeting Abstracts 2011;52:2058.VIEWSuprachorodial Space and Microinjector
ARVO 2011Kang SJ, Patel SR, Berezovsky DE, Zhang Q, Yang H, Grossniklaus HE. - Suprachoroidal Injection of Microspheres with Microcatheter in a Rabbit Model of Uveal Melanoma.VIEWSuprachorodial Space and Microinjector
ARVO 2011Patel SR, Bergman L, Berglin LC, et al. - Surface Area Coverage of Suprachoroidal Injections Using A Hollow Microneedle in Fresh Human Globes.VIEWSuprachorodial Space and Microinjector
ARVO 2012Patel SR. - Targeted Drug Delivery to the Suprachoroidal Space: A Minimally Invasive Approach to Treating Chorioretinal Diseases Using Microneedles.VIEWSuprachorodial Space and Microinjector
AAO 2010Patel SR. - Targeting to the Suprachoroidal Space of the Eye Using a Hollow Microneedle.VIEWSuprachorodial Space and Microinjector
ARVO 2010Berglin LC, Bergman L, Patel SR, et al. - Tracing of Suprachoroidally Microneedle Injected Labeled Drugs and Microbeads in Human, Pig and Rabbit Tissue Using Liquid Nitrogen Snap-Freeze Thaw and Lypholization Techniques.VIEWSuprachorodial Space and Microinjector
ARVO 2008Patel S, Edelhauser HF, Nickerson JM, Prausnitz MR. - Suprachoroidal Drug Delivery Using Microneedles.VIEWSuprachorodial Space and Microinjector
ARVO 2007Prausnitz MR, Jiang J, Patel SR, et al. - Ocular Drug Delivery Using Microneedles.VIEWSuprachorodial Space and Microinjector